Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta.

LXRalpha and -beta are nuclear receptors that regulate the metabolism of several important lipids, including cholesterol and bile acids. Previously, we have proposed that LXRs regulate these pathways through their interaction with specific, naturally occurring oxysterols, including 22(R)-hydroxycholesterol, 24(S)-hydroxycholesterol, and 24(S),25-epoxycholesterol. Using a ligand binding assay that incorporates scintillation proximity technology to circumvent many of the problems associated with assaying extremely hydrophobic ligands, we now demonstrate that these oxysterols bind directly to LXRs at concentrations that occur in vivo. To characterize further the structural determinants required for potent LXR ligands, we synthesized and tested a series of related compounds for binding to LXRs and activation of transcription. These studies revealed that position-specific monooxidation of the sterol side chain is requisite for LXR high-affinity binding and activation. Enhanced binding and activation can also be achieved through the use of 24-oxo ligands that act as hydrogen bond acceptors in the side chain. In addition, introduction of an oxygen on the sterol B-ring results in a ligand with LXRalpha-subtype selectivity. These results support the hypothesis that naturally occurring oxysterols are physiological ligands for LXRs and show that a rational, structure-based approach can be used to design potent LXR ligands for pharmacologic use.

[1]  R. Dixon,et al.  The isolation of crystalline 22R-hydroxycholesterol and 20 alpha, 22R-dihydroxycholesterol from bovine adrenals. , 1970, Biochemical and biophysical research communications.

[2]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[3]  N. Javitt,et al.  Bile acid synthesis in man. II. Determination of 7 alpha-hydroxycholesterol, (22R)-22-hydroxycholesterol, and 26-hydroxycholesterol in human meconium. , 1977, Journal of lipid research.

[4]  J. Nelson,et al.  Enzymic reduction of an epoxide to an alcohol , 1982 .

[5]  K.,et al.  24(S),25-Epoxycholesterol. Evidence consistent with a role in the regulation of hepatic cholesterogenesis. , 1985, The Journal of biological chemistry.

[6]  J. Nelson,et al.  24,25-Epoxysterol metabolism in cultured mammalian cells and repression of 3-hydroxy-3-methylglutaryl-CoA reductase. , 1986, The Journal of biological chemistry.

[7]  H. Motulsky,et al.  Calculating receptor number from binding experiments using same compound as radioligand and competitor. , 1989, Trends in pharmacological sciences.

[8]  T. Kita,et al.  Receptors for modified low-density lipoproteins on human endothelial cells: different recognition for acetylated low-density lipoprotein and oxidized low-density lipoprotein. , 1991, Biochimica et biophysica acta.

[9]  J. Grippo,et al.  9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα , 1992, Nature.

[10]  D. Russell,et al.  Bile acid biosynthesis. , 1992, Biochemistry.

[11]  Gregor Eichele,et al.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor , 1992, Cell.

[12]  M. Pfahl,et al.  A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily , 1994, Molecular and cellular biology.

[13]  R. Hiipakka,et al.  Ubiquitous receptor: a receptor that modulates gene activation by retinoic acid and thyroid hormone receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Chiang,et al.  Identification and characterization of a putative bile acid-responsive element in cholesterol 7 alpha-hydroxylase gene promoter. , 1994, The Journal of biological chemistry.

[15]  K. Umesono,et al.  LXR, a nuclear receptor that defines a distinct retinoid response pathway. , 1995, Genes & development.

[16]  K. Petty Tissue- and cell-specific distribution of proteins that interact with the human thyroid hormone receptor-β , 1995, Molecular and Cellular Endocrinology.

[17]  William Bourguet,et al.  Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α , 1995, Nature.

[18]  R. Hiipakka,et al.  Ubiquitous Receptor: Structures, Immunocytochemical Localization, and Modulation of Gene Activation by Receptors for Retinoic Acids and Thyroid Hormones a , 1995, Annals of the New York Academy of Sciences.

[19]  Mary E. McGrath,et al.  A structural role for hormone in the thyroid hormone receptor , 1995, Nature.

[20]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[21]  B. Shroot,et al.  Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes. , 1995, Journal of medicinal chemistry.

[22]  Jean-Paul Renaud,et al.  Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid , 1995, Nature.

[23]  D. Lütjohann,et al.  Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Mangelsdorf,et al.  An oxysterol signalling pathway mediated by the nuclear receptor LXRα , 1996, Nature.

[25]  Timothy M. Willson,et al.  Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway* , 1997, The Journal of Biological Chemistry.

[26]  S. Blanchard,et al.  Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain. , 1998, Analytical biochemistry.

[27]  R. Hammer,et al.  Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRα , 1998, Cell.

[28]  D. Corey,et al.  Engineering novel specificities for ligand-activated transcription in the nuclear hormone receptor RXR. , 1998, Chemistry & biology.

[29]  B. R. Krause,et al.  ACAT-2, A Second Mammalian Acyl-CoA:Cholesterol Acyltransferase , 1998, The Journal of Biological Chemistry.

[30]  T. Willson,et al.  Peroxisome proliferator activated receptor agonists. , 1997, EXS.